Review article · 2013 · Open access

Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics

John Harding, Oleg Mirochnitchenko

Journal of Biological Chemistry, 289(8), 4585–4593 · Published 21 December 2013 · DOI 10.1074/jbc.r113.463737

Open PDFView at the publisherCite this paper

In brief

“Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics” is a 2013 review article by John Harding and Oleg Mirochnitchenko, published in Journal of Biological Chemistry. OpenAlex counts 67 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Biological Chemistry.

Citations
67
Most cited in
2023 (10)
Field-weighted impact
0.74
References
99
Authors
2

Abstract

Induced pluripotent stem cells (iPSCs) and their differentiated derivatives can potentially be applied to cell-based therapy for human diseases. The properties of iPSCs are being studied intensively both to understand the basic biology of pluripotency and cellular differentiation and to solve problems associated with therapeutic applications. Examples of specific preclinical applications summarized briefly in this minireview include the use of iPSCs to treat diseases of the liver, nervous system, eye, and heart and metabolic conditions such as diabetes. Early stage studies illustrate the potential of iPSC-derived cells and have identified several challenges that must be addressed before moving to clinical trials. These include rigorous quality control and efficient production of required cell populations, improvement of cell survival and engraftment, and development of technologies to monitor transplanted cell behavior for extended periods of time. Problems related to immune rejection, genetic instability, and tumorigenicity must be solved. Testing the efficacy of iPSC-based therapies requires further improvement of animal models precisely recapitulating human disease conditions.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Harding, J., & Mirochnitchenko, O. (2013). Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics. Journal of Biological Chemistry, 289(8), 4585–4593. https://doi.org/10.1074/jbc.r113.463737

MLA 9

Harding, John, and Oleg Mirochnitchenko. “Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics.” Journal of Biological Chemistry, vol. 289, no. 8, 2013, pp. 4585–4593. https://doi.org/10.1074/jbc.r113.463737.

Chicago

Harding, John and Oleg Mirochnitchenko. 2013. “Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics.” Journal of Biological Chemistry 289 (8): 4585–4593. https://doi.org/10.1074/jbc.r113.463737.

Harvard

Harding, J. and Mirochnitchenko, O. (2013) ‘Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics’, Journal of Biological Chemistry, 289(8), pp. 4585–4593. doi:10.1074/jbc.r113.463737.

IEEE

J. Harding and O. Mirochnitchenko, “Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics,” Journal of Biological Chemistry, vol. 289, no. 8, pp. 4585–4593, 2013, doi: 10.1074/jbc.r113.463737.

BibTeX

@article{harding2013preclinical,
  title     = {{Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics}},
  author    = {Harding, John and Mirochnitchenko, Oleg},
  journal   = {Journal of Biological Chemistry},
  year      = {2013},
  volume    = {289},
  number    = {8},
  pages     = {4585--4593},
  doi       = {10.1074/jbc.r113.463737},
  url       = {https://doi.org/10.1074/jbc.r113.463737}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201755
201888
201911
202033
202144
202233
20231010
202411
202544
202611

Its field-weighted citation impact is 0.74: it has been cited 0.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • cell therapy
  • iPSC-derived cells
  • liver disease
  • neurological disorders
  • eye diseases
  • heart disease
  • diabetes mellitus

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Harding, J., & Mirochnitchenko, O. (2013). Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics. Journal of Biological Chemistry, 289(8), 4585–4593. https://doi.org/10.1074/jbc.r113.463737

How many times has this paper been cited?

67 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Biological Chemistry: sign in and open the PDF from this page.

Who wrote this paper?

John Harding, Oleg Mirochnitchenko.

What is the DOI of this paper?

10.1074/jbc.r113.463737, permanently at https://doi.org/10.1074/jbc.r113.463737. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.